Clinical Trials in Austin

Showing 1641-1660 of 7,312 trials

Topical ENS-002 for Atopic Dermatitis in Adults

NCT06469385

The goal of this study is to determine the safety and effects of ENS-002, a live biotherapeutic product (LBP) consisting of commensal, clonal, non-pathogenic bacteria in participants with atopic dermatitis.

Atopic DermatitisAtopic Dermatitis Eczema

Concerto Biosciences9 participantsStarted Sep 2024

Hollywood, Florida, United States • Beverly, Massachusetts, United States • Austin, Texas, United States

COMPLETEDPhase 1< 1 mile

A Study to Evaluate the Safety and Tolerability of Maximal Use Ruxolitinib Cream

NCT06213831

This study is being conducted to determine the safety and tolerability of ruxolitinib 1.5% cream under maximal use conditions in participants with Prurigo Nodularis (PN).

Prurigo Nodularis

Incyte Corporation23 participantsStarted Feb 2024

Phoenix, Arizona, United States • Scottsdale, Arizona, United States • Fountain Valley, California, United States +17 more locations

Topical ENS-002 for Atopic Dermatitis in Adults

A Study to Evaluate the Safety and Tolerability of Maximal Use Ruxolitinib Cream

Find Trials by Condition in Austin

A Study to Evaluate the Efficacy and Safety of 2 Doses of EYE103 Compared With Ranibizumab (0.5 mg) in Participants With DME

Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial

Long Term Extension Study of Tapinarof Cream, 1% for Subjects With Atopic Dermatitis

Evaluation of Non-Invasive Tests for Metabolic Liver Disease

A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular Therapies

CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer

A Study of Seltorexant Compared to Quetiapine XR as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy

To Assess the Efficacy and Safety of INCB054707 in Participants With Hidradenitis Suppurativa

A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic

A Study of Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Clear Cell Renal Cell Carcinoma Post Nephrectomy (MK-6482-022)

Nonalcoholic Fatty Liver Disease (NAFLD) Database 3

Ropeginterferon Alfa-2b (P1101) vs. Anagrelide in Essential Thrombocythemia Patients With Hydroxyurea Resistance or Intolerance

Assessment of the GORE® EXCLUDER® Conformable AAA Endoprosthesis in the Treatment of Abdominal Aortic Aneurysms

A Study to Assess Adverse Events and Change in Disease Condition of Mesalamine Capsules in Children Aged 5 to 17 Years With Ulcerative Colitis

Expanded Access of Sotorasib

Air Optix Plus HydraGlyde Multifocal Daily/Extended Wear Contact Lenses

A First-in-Human Open-label, Phase I/Ib Dose Escalation and Expansion Cohort Study of EOS006215 as Monotherapy and in Combination With Pembrolizumab or Other Anticancer Treatments in Participants With Advanced Solid Tumors

Cessation of Somatostatin Analogues After PRRT in Mid, Hind-Gut and Pancreatic Neuroendocrine Tumours